Targeted Therapy for Interfacial Engineering Toward Stable and Efficient Perovskite Solar Cells

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 31(2019), 41 vom: 04. Okt., Seite e1903691
1. Verfasser: Wang, Shuhui (VerfasserIn)
Weitere Verfasser: Chen, Haiyang, Zhang, Jiandong, Xu, Guiying, Chen, Weijie, Xue, Rongming, Zhang, Moyao, Li, Yaowen, Li, Yongfang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article fullerene derivatives passivation perovskite solar cells water resistance
Beschreibung
Zusammenfassung:© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
The poor long-term stability of organic-inorganic hybrid halide perovskite solar cells (pero-SCs) remains a big challenge for their commercialization. Although strategies such as encapsulation, doping, and passivation have been reported, there remains a lack of understanding of the water resistance and thermal stability of pero-SCs. A fullerene derivative, [6,6]-phenyl-C61 -butyric acid-N,N-dimethyl-3-(2-thienyl)propanam ester (PCBB-S-N) containing a functional sulfur atom and C60, is synthesized and employed as electron transporting layer (ETL)/intermediary layer to targetedly heal the multitype defects in pero-SCs or assist the growth of ETL, such as [6,6]-phenyl-C61 -butyric acid methyl ester (PCBM), in planar p-i-n pero-SCs. The repaired pero-SCs can not only dramatically improve their power conversion efficiencies, but also address stability issues under moisture and high temperature. The corresponding mechanism of PCBB-S-N with targeted therapy effect in a device is systematically investigated by both experiments and theoretical calculation. This work demonstrates that the proposed fullerene derivative with finely tuned chemical structure can be a promising ETL candidate or intermediary to approach stable and efficient planar p-i-n pero-SCs
Beschreibung:Date Completed 14.10.2019
Date Revised 30.09.2020
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.201903691